BioCentury | Apr 2, 2007
Company News

Progen Industries cancer news

...Progen Industries changed its name to Progen Pharmaceuticals Ltd. Progen Industries Ltd. (ASX:PGL; PGLA), Brisbane, Australia Business: Cancer WIR...
BioCentury | Jan 22, 2007
Company News

Medigen, Progen Industries deal

...shares and two-year options to purchase 1 million shares. Medigen Biotechnology Corp. , Taipei, Taiwan Progen Industries Ltd....
BioCentury | Dec 18, 2006
Clinical News

PI-88: Preliminary Phase II data

...unexpected and confirms the highest, safe and effective dose of PI-88 to be 160 mg. Progen Industries Ltd....
BioCentury | Dec 4, 2006
Clinical News

PI-88: Phase III start

...Next year, PGL will begin a Phase III trial. Progen Industries Ltd. (ASX:PGL; PGLA), Brisbane, Australia Product: PI-88...
BioCentury | Apr 3, 2006
Clinical News

PI-88: Phase III start

...year a Phase III trial in chemotherapy-naïve advanced melanoma patients with PI-88 plus dacarbazine (DTIC). Progen Industries Ltd....
BioCentury | Mar 20, 2006
Clinical News

PI-88: Phase II start

...began an open-label, Australian Phase II trial in 118 patients with PI-88 plus dacarbazine (DTIC). Progen Industries Ltd....
BioCentury | Feb 27, 2006
Company News

Progen Industries management update

Progen Industries Ltd. (ASX:PGL; PGLAF), Brisbane, Australia Business: Cancer Hired: Justus Homburg as CEO, formerly CEO of Chirogen Pty Ltd.; he replaces Lewis Lee, who resigned as managing director and a board member WIR Staff...
BioCentury | Aug 15, 2005
Clinical News

PI-88: Phase II started

...evaluate PI-88 plus Taxotere docetaxel. Taxotere is marketed by sanofi-aventis Group (Euronext:SAN; SNY, Paris, France). Progen Industries Ltd....
BioCentury | Aug 1, 2005
Company News

ChemGenex Pharmaceuticals board of directors update

...Ltd. (ASX:CXS; CXSP), Melbourne, Australia Business: Cancer, Metabolic, Neurology Appointed: Patrick Burns, a director of Progen Industries Ltd....
BioCentury | May 30, 2005
Clinical News

PI-88: Phase II started

...Australian Phase II trial in about 100 patients with PI-88 in combination with dacarbazine (DTIC). Progen Industries Ltd....
Items per page:
1 - 10 of 58
BioCentury | Apr 2, 2007
Company News

Progen Industries cancer news

...Progen Industries changed its name to Progen Pharmaceuticals Ltd. Progen Industries Ltd. (ASX:PGL; PGLA), Brisbane, Australia Business: Cancer WIR...
BioCentury | Jan 22, 2007
Company News

Medigen, Progen Industries deal

...shares and two-year options to purchase 1 million shares. Medigen Biotechnology Corp. , Taipei, Taiwan Progen Industries Ltd....
BioCentury | Dec 18, 2006
Clinical News

PI-88: Preliminary Phase II data

...unexpected and confirms the highest, safe and effective dose of PI-88 to be 160 mg. Progen Industries Ltd....
BioCentury | Dec 4, 2006
Clinical News

PI-88: Phase III start

...Next year, PGL will begin a Phase III trial. Progen Industries Ltd. (ASX:PGL; PGLA), Brisbane, Australia Product: PI-88...
BioCentury | Apr 3, 2006
Clinical News

PI-88: Phase III start

...year a Phase III trial in chemotherapy-naïve advanced melanoma patients with PI-88 plus dacarbazine (DTIC). Progen Industries Ltd....
BioCentury | Mar 20, 2006
Clinical News

PI-88: Phase II start

...began an open-label, Australian Phase II trial in 118 patients with PI-88 plus dacarbazine (DTIC). Progen Industries Ltd....
BioCentury | Feb 27, 2006
Company News

Progen Industries management update

Progen Industries Ltd. (ASX:PGL; PGLAF), Brisbane, Australia Business: Cancer Hired: Justus Homburg as CEO, formerly CEO of Chirogen Pty Ltd.; he replaces Lewis Lee, who resigned as managing director and a board member WIR Staff...
BioCentury | Aug 15, 2005
Clinical News

PI-88: Phase II started

...evaluate PI-88 plus Taxotere docetaxel. Taxotere is marketed by sanofi-aventis Group (Euronext:SAN; SNY, Paris, France). Progen Industries Ltd....
BioCentury | Aug 1, 2005
Company News

ChemGenex Pharmaceuticals board of directors update

...Ltd. (ASX:CXS; CXSP), Melbourne, Australia Business: Cancer, Metabolic, Neurology Appointed: Patrick Burns, a director of Progen Industries Ltd....
BioCentury | May 30, 2005
Clinical News

PI-88: Phase II started

...Australian Phase II trial in about 100 patients with PI-88 in combination with dacarbazine (DTIC). Progen Industries Ltd....
Items per page:
1 - 10 of 58